When the physical plant is built, the digital twin can then be used in parallel to monitor operations (a concept known as a living twin): sensor streams from the real plant (temperatures, pressures, flow rates) could be fed into the twin, enabling early detection of drift or faults
[1] [2] These medications belong to different classes of glucose-lowering agents for type 2 diabetes: Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-weekly subcutaneous injection, whilst Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor taken orally once daily
pharmaceutical company Amgen is developing a therapy that combines a GLP-1 drug with a monoclonal antibody, an engineered antibody
We focus on the pharmacokinetic and pharmacodynamic properties of the recently approved oral GLP-1 receptor agonist, oral semaglutide
lactis at the intestinal level which allows for detection of TAT-GFP protein in the tissue, mice were chronically treated (7 or 28 days
Triptolide-induced apoptosis is dependent on caspase activation and NFkB signaling and mediated by XIAP and survivin downregulation through the mitochondrial pathway in leukemic cells